Evidence map›Paper›PMID 31926564›Full record

ArticleJournal of neuroinflammation2020

Dectin-1/Syk signaling triggers neuroinflammation after ischemic stroke in mice.

Xin-Chun Ye, Qi Hao, Wei-Jing Ma, Qiu-Chen Zhao, Wei-Wei Wang, Han-Han Yin, Tao Zhang, Miao Wang, Kun Zan, Xin-Xin Yang and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 129 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Synthetic Ligands of Myeloid C-Type Lectin Receptors.Chembiochem : a European journal of chemical biology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Microglial dectin-1/Frontiers in immunology · 2026
    Article
  16. Review
  17. Amorfrutin A ameliorates cerebral ischemia/reperfsion injuryThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Article
  18. Review
  19. Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Xin-Chun YeInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China. xinchunye@xzhmu.edu.cn.
Qi HaoDepartment of Neurology, Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Xuzhou, People's Republic of China.
Wei-Jing MaInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Qiu-Chen ZhaoDepartment of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China.
Wei-Wei WangDepartment of Rehabilitation Medicine, Linyi Cancer Hospital, Shandong, People's Republic of China.
Han-Han YinInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Tao ZhangInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Miao WangInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Kun ZanInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Xin-Xin YangInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Zuo-Hui ZhangInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Hong-Juan ShiInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Jie ZuInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Hafiz Khuram RazaInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Xue-Ling ZhangDepartment of Neurology, Suqian People's Hospital of Nanjing Drum tower Hospital Group, Suqian, Jiangsu, People's Republic of China.
De-Qin GengInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China.
Jin-Xia HuInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China. jinxia0819@163.com.
Gui-Yun CuiInstitute of Stroke Center and Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, People's Republic of China. guiyuncui@foxmail.com.
Xuzhou Medical College · CNNanjing Drum Tower Hospital · CN

Funding

Jiangsu Commission of Heath LGY2019086Jiangsu Provincial Medical Youth Talent No. QNRC2016788National Natural Science Foundation of China 81571210 and 81771282National Natural Science Foundation of China 81971134 and 81571155Natural Science Foundation of Jiangsu Province BK20150209Natural Science Foundation of Jiangsu Province BK20191152Natural Science Foundation of Jiangsu Province BL2014031Natural Science Foundation of the Higher Education Institutions of Jiangsu Province 17KJB320017Suqian Science and Technology Plan S201714the Summit of Six Top Talents Program of Jiangsu Province 2017-WSN-118Xuzhou Innovation Capacity Building Program KC19239Xuzhou key research and development program KC18055Xuzhou key research and development program KC19131
6 · The paper itself

Abstract

backgroundDendritic cell-associated C-type lectin-1 (Dectin-1) receptor has been reported to be involved in neuroinflammation in Alzheimer's disease and traumatic brain injury. The present study was designed to investigate the role of Dectin-1 and its downstream target spleen tyrosine kinase (Syk) in early brain injury after ischemic stroke using a focal cortex ischemic stroke model.

methodsAdult male C57BL/6 J mice were subjected to a cerebral focal ischemia model of ischemic stroke. The neurological score, adhesive removal test, and foot-fault test were evaluated on days 1, 3, 5, and 7 after ischemic stroke. Dectin-1, Syk, phosphorylated (p)-Syk, tumor necrosis factor-α (TNF-α), and inducible nitric oxide synthase (iNOS) expression was analyzed via western blotting in ischemic brain tissue after ischemic stroke and in BV2 microglial cells subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) injury in vitro. The brain infarct volume and Iba1-positive cells were evaluated using Nissl's and immunofluorescence staining, respectively. The Dectin-1 antagonist laminarin (LAM) and a selective inhibitor of Syk phosphorylation (piceatannol; PIC) were used for the intervention.

resultsDectin-1, Syk, and p-Syk expression was significantly enhanced on days 3, 5, and 7 and peaked on day 3 after ischemic stroke. The Dectin-1 antagonist LAM or Syk inhibitor PIC decreased the number of Iba1-positive cells and TNF-α and iNOS expression, decreased the brain infarct volume, and improved neurological functions on day 3 after ischemic stroke. In addition, the in vitro data revealed that Dectin-1, Syk, and p-Syk expression was increased following the 3-h OGD and 0, 3, and 6 h of reperfusion in BV2 microglial cells. LAM and PIC also decreased TNF-α and iNOS expression 3 h after OGD/R induction.

conclusionDectin-1/Syk signaling plays a crucial role in inflammatory activation after ischemic stroke, and further investigation of Dectin-1/Syk signaling in stroke is warranted.

Indexed as

AnimalsBrain IschemiaDectin-1InflammationLectins, C-TypeMaleMiceMice, Inbred C57BLSignal TransductionStrokeSyk KinaseDectin-1Lectins, C-TypeSyk KinaseSyk protein, mouseDectin-1inflammationischemic strokeSyk

Identifiers

PMID31926564
PMCPMC6954534
OpenAlexW3000131234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.